LISOTTI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 5.610
AS - Asia 4.501
EU - Europa 3.044
SA - Sud America 285
AF - Africa 257
OC - Oceania 7
Totale 13.704
Nazione #
US - Stati Uniti d'America 5.549
SG - Singapore 1.527
CN - Cina 1.208
VN - Vietnam 797
GB - Regno Unito 742
DE - Germania 483
HK - Hong Kong 426
IT - Italia 415
SE - Svezia 377
IN - India 236
BR - Brasile 204
RU - Federazione Russa 194
IE - Irlanda 191
NL - Olanda 146
FR - Francia 129
KR - Corea 120
ZA - Sudafrica 79
UA - Ucraina 77
EE - Estonia 60
TG - Togo 53
CI - Costa d'Avorio 52
JO - Giordania 51
CH - Svizzera 50
JP - Giappone 44
BG - Bulgaria 41
AR - Argentina 39
FI - Finlandia 36
ID - Indonesia 31
CA - Canada 30
NG - Nigeria 26
AT - Austria 23
MX - Messico 21
BE - Belgio 20
PL - Polonia 19
EC - Ecuador 16
SC - Seychelles 16
EG - Egitto 11
BD - Bangladesh 10
TR - Turchia 9
PY - Paraguay 7
CL - Cile 6
LT - Lituania 6
TN - Tunisia 6
CO - Colombia 5
DZ - Algeria 5
GR - Grecia 5
IQ - Iraq 5
IR - Iran 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
KW - Kuwait 4
LB - Libano 4
MK - Macedonia 4
PE - Perù 4
AU - Australia 3
DK - Danimarca 3
KE - Kenya 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
UY - Uruguay 3
AL - Albania 2
ES - Italia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
LK - Sri Lanka 2
MA - Marocco 2
NI - Nicaragua 2
PA - Panama 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
HN - Honduras 1
JM - Giamaica 1
KZ - Kazakistan 1
MD - Moldavia 1
ML - Mali 1
MY - Malesia 1
NC - Nuova Caledonia 1
PT - Portogallo 1
VG - Isole Vergini Britanniche 1
Totale 13.704
Città #
Singapore 1.006
Fairfield 683
Southend 667
Ashburn 638
Chandler 463
Hong Kong 422
Hefei 279
Santa Clara 278
Houston 264
Wilmington 254
Seattle 250
Woodbridge 244
Cambridge 206
Princeton 201
Dublin 191
Ho Chi Minh City 186
Boardman 183
Beijing 175
Dong Ket 173
Ann Arbor 148
Hanoi 137
Seoul 115
Bologna 106
Dallas 95
Los Angeles 75
Westminster 68
Nanjing 67
Berlin 61
Milan 56
Buffalo 53
Lomé 53
Abidjan 52
Amman 51
Redondo Beach 48
Bern 44
Padova 43
San Diego 42
Sofia 41
New York 40
Saint Petersburg 38
Tokyo 38
Jinan 37
Munich 35
Frankfurt am Main 32
Bengaluru 29
Medford 29
Jacksonville 27
Dearborn 25
Shenyang 25
Des Moines 24
Guangzhou 23
Florence 22
Abeokuta 21
Changsha 21
Shanghai 21
Tianjin 21
Helsinki 20
São Paulo 20
Brussels 19
Da Nang 19
Hebei 19
Jakarta 19
Chicago 17
Nuremberg 17
Olalla 17
Zhengzhou 17
Xi'an 16
Falls Church 15
Haiphong 15
Nanchang 15
Phoenix 15
Redwood City 15
Turin 15
Bremen 14
Falkenstein 14
Vienna 14
Wuhan 13
Ha Long 12
Mülheim 12
Pune 12
Toronto 12
Council Bluffs 11
Biên Hòa 10
Hangzhou 10
London 10
Montreal 10
Norwalk 10
San Francisco 10
Taizhou 10
Turku 10
Warsaw 10
Amsterdam 9
Brooklyn 9
Chengdu 9
Hải Dương 9
Jiaxing 9
Johannesburg 9
Rome 9
Brasília 8
Bühl 8
Totale 9.199
Nome #
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 213
Sustained virological response after 4-week ritonavir-boosted paritaprevir, ombitasvir and dasabuvir plus ribavirin treatment in a kidney transplant recipient 212
Berberine and its metabolites: Relationship between physicochemical properties and plasma levels after administration to human subjects 203
The clinical impact of ultrasound contrast agents in EUS: a systematic review according to the levels of evidence 198
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 197
Catheter probe extraductal ultrasound (EDUS) exploration of the common bile duct is safe in elderly patients with suspicion of choledocholithiasis after distal gastrectomy 195
High Doses of Ursodeoxycholic Acid Up-Regulate the Expression of Placental Breast Cancer Resistance Protein in Patients Affected by Intrahepatic Cholestasis of Pregnancy 189
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 180
Basics in Endoscopic Ultrasound Part 1: Diagnostic Indications and Tissue Sampling 180
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 175
Reactivation of Crohn's disease after pandemic aH1N1 and seasonal flu vaccinations. 173
Alisporivir for the treatment of chronic HCV 168
Severe immune thrombocytopenia after peg-interferonalpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature 161
Combining contrast harmonic and elastography during EUS examination of pancreatic tumors increases diagnostic accuracy 160
Basics in Endoscopic Ultrasound Part 2: EUS-guided sampling and therapeutic applications 159
CO 2 vs. air insufflation in endoscopic ultrasonography: a prospective study 158
Endoscopic Ultrasound Guided Biliary Drainage in Malignant Distal Biliary Obstruction 155
Chronic NSAIDs Therapy and Upper Gastrointestinal Tract – Mechanism of Injury, Mucosal Defense, Risk Factors for Complication Development and Clinical Management 152
Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma 150
Contrast-enhanced endoscopic ultrasound for the differential diagnosis between benign and malignant lymph nodes: a meta-analysis 150
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 148
Reliability of endoscopic ultrasound in predicting the number and size of common bile duct stones before endoscopic retrograde cholangiopancreatography 146
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 144
Proton pump inhibitors in cirrhosis: tradition or evidence based practice? 142
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update 140
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 139
Elective cholecystectomy after reversal of septic shock using multimodality endoscopic gallbladder drainage 137
Severe hypernatremia as a predictor of mortality after percutaneous endoscopic gastrostomy (PEG) placement 136
Standard Bismuth Quadruple Therapy versus Concomitant Therapy for the First-Line Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 135
Noninvasive diagnosis of portal hypertension and esophageal varices through the identification of liver blood flow markers 135
Indocyanine green clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis. 135
Repeated endoscopic ultrasound-guided fine-needle biopsy of solid pancreatic lesions after previous nondiagnostic or inconclusive sampling 133
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis 133
Reply 132
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 131
Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of localized gallbladder lesions 130
Diagnostic accuracy for neoplastic IPMN: does the contrast make the difference? 130
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. 128
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 128
Role of contrast harmonic-endoscopic ultrasound in pancreatic cystic lesions 127
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. 127
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors 126
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 125
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 125
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis 125
Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis 124
Endoscopic ultrasound-guided treatments: are we getting evidence based--a systematic review. 123
Conservative management of malignant gastric outlet obstruction syndrome-evidence based evaluation of endoscopic ultrasound-guided gastroentero-anastomosis 123
High dose lamivudine in HBV-related cirrhotic patients with unsatisfactory response after adefovir add-on 122
Proctosigmoidite ulcerosa refrattaria e recidivante alla terapia topica trattata con beclometasone dipropionato orale 122
Performance of the forward-view echoendoscope for pancreaticobiliary examination in patients with status post-upper gastrointestinal surgery 122
Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of submucosal tumors of the upper gastrointestinal tract 121
NSAIDs-induced upper gastrointestinal bleeding in hepatitis B virus-positive patient with acute kidney injury - nonocclusive mesenteric ischemia 121
Indocyanine green retention test as a non-invasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. 120
EUS liver assessment using contrast agents and elastography 120
Extracorporeal shock wave lithotripsy for difficult common bile duct stones: a comparison between 2 different lithotripters in a large cohort of patients. 119
Diagnostic performance of endoscopic ultrasound-guided tissue acquisition of splenic lesions: systematic review with pooled analysis 117
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. 115
Role of endoscopy in the conservative management of biliary complications after deceased donor liver transplantation 114
Intracystic Glucose Measurement for On-Site Differentiation Between Mucinous and Non-Mucinous Pancreatic Cystic Lesions 113
Methods for Drainage of Distal Malignant Biliary Obstruction after ERCP Failure: A Systematic Review and Network Meta‐Analysis 113
Severe acute autoimmune hepatitis after natalizumab treatment. 113
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY 113
Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience 111
The pharmacological management of intrahepatic cholestasis of pregnancy. 108
Contrast enhancement and elastography in endoscopic ultrasound: an update of clinical applications in pancreatic diseases 108
Contrast Enhanced EUS for Predicting Solid Pancreatic Neuroendocrine Tumor Grade and Aggressiveness 106
Endoscopic Ultrasound-Guided Locoregional Treatments for Pancreatic Neuroendocrine Neoplasms 104
Pancreatic necrosectomy: an evidence-based systematic review of the levels of evidence and a comparison of endoscopic versus non-endoscopic techniques 103
Palliative care in patients with liver cirrhosis: it is the time to deal with the burden 102
Safety and efficacy of endoscopic ultrasound‐guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta‐analysis 100
Endoscopic Ultrasound-Guided Pancreatic Cystic Fluid Biochemical and Genetic Analysis for the Differentiation Between Mucinous and Non-Mucinous Pancreatic Cystic Lesions 100
Contrast-enhanced EUS for the differential diagnosis of lymphadenopathy: technical improvement with defined indications 98
EUS-guided transrectal drainage of pelvic fluid collections using electrocautery-enhanced lumen-apposing metal stents: a case series 97
Endoscopic ultrasound fine-needle biopsy vs fine-needle aspiration for lymph nodes tissue acquisition: A systematic review and meta-Analysis 96
Evaluation of a new slim radial echoendoscope: A better option for an aging population 96
Contrast-enhanced harmonic endoscopic ultrasound-guided ethanol injection for a small hepatocellular carcinoma 96
Treatment of acute hepatitis B with high dose lamivudine 93
EUS-guided gallbladder drainage in high-risk surgical patients with acute cholecystitis—procedure outcomes and evaluation of mortality predictors 93
Repeat EUS-FNA of pancreatic masses after nondiagnostic or inconclusive results: systematic review and meta-analysis 92
Contrast Harmonic-Enhanced Endoscopic Ultrasound (EUS) Is the Perfect Companion of EUS-Guided Tumor Ablation 92
Contrast-enhanced EUS for the characterization of mural nodules within pancreatic cystic neoplasms: systematic review and meta-analysis 92
Contrast Harmonic-Endoscopic Ultrasound Is Useful to Identify Neoplastic Features of Pancreatic Cysts (With Videos) 91
Endoscopic ultrasound-guided gallbladder drainage as a strategy to overcome shortage of operating rooms and intensive care unit beds during Covid-19 crisis 90
Colonoscopy-related colonic ischemia 89
Rare pancreatic/peripancreatic cystic lesions can be accurately characterized by EUS with through-the-needle biopsy — A unique pictorial essay with clinical and histopathological correlations 86
Risk Factors for Common Bile Duct Stones in Patients with Previous Cholecystectomy: A Multicenter Prospective Proof-of-Concept Study 85
Endoscopic ultrasound assessment and tissue acquisition of mediastinal and abdominal lymph nodes 85
Factors influencing surgical indication in patients with asymptomatic pancreatic cystic lesion – is EUS always indicated before surgery? 81
null 80
Effectiveness and safety of underwater techniques in gastrointestinal endoscopy: a comprehensive review of the literature 77
Routine EUS-guided tissue acquisition in patients with resectable solid pancreatic masses - Pros and cons reassessment in 2020 76
Prediction of the Risk of Lymph Node Metastases in Early Gastric Cancer: Contrast-Enhanced Harmonic Endoscopic Ultrasonography May Help 76
Tumor Location in the Head/Uncinate Process and Presence of Fibrosis Impair the Adequacy of Endoscopic Ultrasound-Guided Tissue Acquisition of Solid Pancreatic Tumors 74
EUS-guided gallbladder drainage during a pandemic crisis - How the COVID-19 outbreak could impact interventional endoscopy 74
Failed endoscopic ultrasound-guided gallbladder drainage due to severe bleeding immediately rescued by redo-drainage under contrast-harmonic guidance 73
Contrast-enhanced harmonic endoscopic ultrasonography: Additional tool to predict clinical behavior of pancreatic neuroendocrine neoplasms 71
Detection of occult liver metastases during EUS: Does the contrast make the difference? 69
Endoscopic ultrasound-guided jejuno-jejunal anastomosis for malignant outlet obstruction after total gastrectomy 68
Endoscopic ultrasound- versus ERCP-guided primary drainage of inoperable malignant distal biliary obstruction: systematic review and meta-analysis of randomized controlled trials 67
Totale 12.299
Categoria #
all - tutte 42.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.919


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021582 0 0 0 0 0 25 7 43 118 33 40 316
2021/20221.737 108 45 72 91 151 71 106 117 76 52 571 277
2022/20231.982 206 256 89 247 155 159 79 121 414 24 117 115
2023/2024633 23 121 42 89 39 119 22 28 54 42 16 38
2024/20252.804 107 407 233 170 473 136 138 58 46 214 187 635
2025/20263.318 730 622 620 443 733 170 0 0 0 0 0 0
Totale 13.993